Arca Biopharma Stock Price on December 2, 2021 Breakdown

ABIO -  USA Stock  

USD 2.35  0.06  2.62%

Arca Biopharma Stock price history is provided at the adjusted basis, taking into account all of the recent filings. As of today, the current price of Arca Biopharma is  2.35 , as last reported on the 18th of May 2022, with the highest price reaching  2.35  and the lowest price hitting  2.31  during the day.
Arca Biopharma appears to be slightly risky, given 3 months investment horizon. Arca Biopharma secures Sharpe Ratio (or Efficiency) of 0.16, which signifies that the company had 0.16% of return per unit of standard deviation over the last 3 months. Our philosophy in foreseeing the volatility of a stock is to use all available market data together with stock-specific technical indicators that cannot be diversified away. We have found twenty-seven technical indicators for Arca Biopharma, which you can use to evaluate the future volatility of the firm. Please makes use of Arca Biopharma's mean deviation of 2.26, and Risk Adjusted Performance of 0.1474 to double-check if our risk estimates are consistent with your expectations.
The value of Net Income Common Stock is estimated to slide to about (19.8 M). Arca Biopharma Price to Book Value is quite stable at the moment as compared to the past year. The company's current Price to Book Value is estimated at 0.86. Price to Sales Ratio is expected to rise to 2.46 this year, although the value of Price to Earnings Ratio will most likely fall to (1.67) .

Arca Biopharma Main Headline on 2nd of December 2021

Financial Statements
by SEC
Financial Statements and Exhibits. Other Events

Arca Biopharma Valuation on December 2, 2021

It is possible to determine the worth of Arca Biopharma on a given historical date. On December 2, 2021 Arca Biopharma was worth 2.32 at the beginning of the trading date compared to the closed value of 2.25. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Arca Biopharma stock. Still, in general, we apply an absolute valuation method to find Arca Biopharma's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Visa where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Arca Biopharma's related companies.
 Open High Low Close Volume
  2.42    2.42    2.25    2.27    597,476  
  2.32    2.35    2.23    2.25    437,294  
  2.28    2.33    2.18    2.25    611,411  
Backtest Arca Biopharma  |  Arca Biopharma History  |  Arca Biopharma Valuation   PreviousNext  
Open Value 2.32
Closing Value

Arca Biopharma Trading Date Momentum on December 2, 2021

On December 03 2021 Arca Biopharma was traded for  2.25  at the closing time. The top price for the day was 2.33  and the lowest listed price was  2.18 . The trading volume for the day was 611.4 K. The trading history from December 3, 2021 did not affect price variability. The overall trading delta against the current closing price is 2.67% .

Arca Biopharma Fundamentals Correlations and Trends

By evaluating Arca Biopharma's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Arca Biopharma's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Arca Biopharma financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Arca Biopharma Stock history

Arca Biopharma investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Arca Biopharma is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Arca Biopharma will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Arca Biopharma historical stock prices may prove useful in developing a viable investing in Arca Biopharma
Last ReportedProjected for 2022
Weighted Average Shares13.9 M15 M
Weighted Average Shares Diluted13.9 M15 M
Issuance Purchase of Equity Shares24.1 M21.1 M
ARCA biopharma, Inc., a clinical-stage biopharmaceutical company, develops and commercializes genetically targeted therapies for cardiovascular diseases. ARCA biopharma, Inc. is headquartered in Westminster, Colorado. Arca Biopharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people.

Arca Biopharma Quarterly Market Capitalization

33.14 Million


Arca Biopharma Stock Technical Analysis

Arca Biopharma technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Arca Biopharma technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Arca Biopharma trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Arca Biopharma Period Price Range

December 2, 2021





Arca Biopharma May 18, 2022 Market Strength

Market strength indicators help investors to evaluate how Arca Biopharma stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Arca Biopharma shares will generate the highest return on investment. By undertsting and applying Arca Biopharma stock market strength indicators, traders can identify Arca Biopharma entry and exit signals to maximize returns

Arca Biopharma Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Arca Biopharma stock's direction in advance. Along with the technical and fundamental analysis of Arca Biopharma Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Arca Biopharma to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen stock market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Please continue to Trending Equities. Note that the Arca Biopharma information on this page should be used as a complementary analysis to other Arca Biopharma's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Arca Biopharma Stock analysis

When running Arca Biopharma price analysis, check to measure Arca Biopharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arca Biopharma is operating at the current time. Most of Arca Biopharma's value examination focuses on studying past and present price action to predict the probability of Arca Biopharma's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Arca Biopharma's price. Additionally, you may evaluate how the addition of Arca Biopharma to your portfolios can decrease your overall portfolio volatility.
Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Equity Valuation
Check real value of public entities based on technical and fundamental data
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Money Managers
Screen money managers from public funds and ETFs managed around the world
Is Arca Biopharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Arca Biopharma. If investors know Arca Biopharma will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Arca Biopharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Arca Biopharma is measured differently than its book value, which is the value of Arca Biopharma that is recorded on the company's balance sheet. Investors also form their own opinion of Arca Biopharma's value that differs from its market value or its book value, called intrinsic value, which is Arca Biopharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Arca Biopharma's market value can be influenced by many factors that don't directly affect Arca Biopharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Arca Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine Arca Biopharma value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Arca Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.